2Kyle RA. Long-term survival in multiple myeloma[J]. N Engl J Med, 1983,308(3) :314-316.
3Kyle RA. Multiple myeloma: review of 869 cases[J ]. Mayo Clin Proc, 1975,50(1) :29-40.
4Morgan GJ,Davies FE,I.inet M. Myeloma aetiology and epidemiology[J]. Biomed Pharmacother,2002,56(3) :223 - 234.
5Lipworth L, Tarone RE, Mc Laughlin JK. The epidemiology of renal cell carcinoma[J].- J Urol, 2006,176 ( 11 ) :2353 - 2358.
6Kurtz JE, Andres E, Maloisel F, et al. Renal clear-cell adenocarcinoma and type B lymphomatous proliferation : a fortuitous association? [J]. RevMed Intern,1999,20(3):329-332.
8Sakai A, Kawano M,Kuramoto A. Interleukin- 6 produced by renal-cell carcinoma cells and progression of multiple myeloma[J]. N Engl J Med,1991,324(13) :1893- 1894.
9Gregersen H, Mellemkjaer L, Sailing I J, et al. Cancer risk in patients with monoclonal-gammopathy of undetermined significance [J]. Am J Hematol,2000,63 ( 1 ) : 1 - 6.
10Schaar CG,Snijder S,Oostindier MJ. Monoclonal proteinaemia and solid tumours[J]. EurJ Can,2004,40(11):1539-1544.